- Home
- LNTH vs CNO Comparison
LNTH vs CNO Comparison
Compare LNTH & CNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CNO
- Stock Information
- Founded
- LNTH 1956
- CNO 1979
- Country
- LNTH United States
- CNO United States
- Employees
- LNTH N/A
- CNO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CNO Accident &Health Insurance
- Sector
- LNTH Health Care
- CNO Finance
- Exchange
- LNTH Nasdaq
- CNO Nasdaq
- Market Cap
- LNTH 3.8B
- CNO 3.8B
- IPO Year
- LNTH 2015
- CNO 1987
- Fundamental
- Price
- LNTH $53.11
- CNO $39.90
- Analyst Decision
- LNTH Buy
- CNO Hold
- Analyst Count
- LNTH 6
- CNO 5
- Target Price
- LNTH $74.17
- CNO $43.60
- AVG Volume (30 Days)
- LNTH 1.2M
- CNO 582.4K
- Earning Date
- LNTH 11-06-2025
- CNO 11-03-2025
- Dividend Yield
- LNTH N/A
- CNO 1.70%
- EPS Growth
- LNTH N/A
- CNO 20.08
- EPS
- LNTH 2.39
- CNO 2.98
- Revenue
- LNTH $1,525,933,000.00
- CNO $4,441,500,000.00
- Revenue This Year
- LNTH N/A
- CNO N/A
- Revenue Next Year
- LNTH $1.98
- CNO $3.27
- P/E Ratio
- LNTH $21.94
- CNO $13.41
- Revenue Growth
- LNTH 1.95
- CNO N/A
- 52 Week Low
- LNTH $47.25
- CNO $34.63
- 52 Week High
- LNTH $111.29
- CNO $43.20
- Technical
- Relative Strength Index (RSI)
- LNTH 46.34
- CNO 47.60
- Support Level
- LNTH $51.47
- CNO $39.69
- Resistance Level
- LNTH $55.55
- CNO $41.83
- Average True Range (ATR)
- LNTH 2.61
- CNO 0.94
- MACD
- LNTH -0.30
- CNO -0.08
- Stochastic Oscillator
- LNTH 27.84
- CNO 28.47
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.